Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)

PURPOSE: Cisplatin plus 5-fluorouracil has been globally accepted as a standard regimen for the treatment for advanced gastric cancer. However, cisplatin has several disadvantages, including renal toxicity and the need for admission. S-1 plus cisplatin has become a standard treatment for advanced ga...

Descripción completa

Detalles Bibliográficos
Autores principales: Koizumi, Wasaburo, Kim, Yeul Hong, Fujii, Masashi, Kim, Hoon Kyo, Imamura, Hiroshi, Lee, Kyung Hee, Hara, Takuo, Chung, Hyun Cheol, Satoh, Taroh, Cho, Jae Yong, Hosaka, Hisashi, Tsuji, Akihito, Takagane, Akinori, Inokuchi, Mikito, Tanabe, Kazuaki, Okuno, Tatsuya, Ogura, Mariko, Yoshida, Kazuhiro, Takeuchi, Masahiro, Nakajima, Toshifusa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895196/
https://www.ncbi.nlm.nih.gov/pubmed/24366758
http://dx.doi.org/10.1007/s00432-013-1563-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895196/
https://www.ncbi.nlm.nih.gov/pubmed/24366758
http://dx.doi.org/10.1007/s00432-013-1563-5

Ejemplares similares